Prior authorization & UM · Medication access / PA
Develop Health
Develop Health is an EHR-integrated benefits verification and prior authorization platform focused on medication access, including drafting, status, and appeals for pharmacy-benefit pathways. It is not a payer clinical utilization-management policy engine.
Strong fit
- Digital health and specialty clinics drowning in pharmacy-benefit prior authorization for high-friction drugs
- Teams measuring approval turnaround, form completion time, and medication start rates
- Organizations that want EHR-integrated benefits checks and PA drafting without a full payer UM suite
Weak fit
- Health plans buying enterprise utilization-management policy engines
- Providers whose prior auth volume is almost entirely medical-benefit procedures, with little medication PA work
- Buyers who will not let staff review AI-drafted clinical answers before submission
Bottom line
Develop Health earns a Recommend for mid-market digital health and specialty providers focused on medication access friction. The platform covers benefits verification, prior authorization package generation, status, and appeals for pharmacy-benefit paths such as GLP-1s and specialty therapies. Public ARR estimates sit in the single-digit to low-teen millions after a 2025 Series A, which fits this mid-market station. Product depth is narrower than Infinitus-style voice agents across all access calls or Xsolis-style UM. Implementation still needs EHR integration and clear exception ownership. Pricing is quote-based. Score sits near SamaCare for a medication-access shaped PA problem.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Develop Health automates benefits verification and prior authorization for medication access, with EHR-integrated drafting, status, and appeals support. Early traction is strongest with digital health and specialty pharmacy-benefit pathways.
It is not a payer clinical UM determination suite. Compare Infinitus when phone-based access work dominates, and SamaCare when medical-benefit specialty PA is the main queue.
Score reflects a focused mid-market product with ordinary pricing opacity.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Develop Health | 7.0 | 6.8 |
| Infinitus | 7.7 | 7.4 |
| SamaCare | 7.1 | 7.0 |
| Valer | 6.6 | 6.4 |
| Rhyme | 6.5 | 6.3 |
Pricing
| Item | Detail |
|---|---|
| Model | EHR-integrated benefits verification and prior authorization automation for medication access; quote-based. |
| What usually drives cost | Submission volume, drug and specialty mix, EHR integration depth, and appeals modules. |
| What to ask in diligence | Cost per successful authorization versus staff time saved, with approval-rate baselines written into the pilot. |
| Published pricing | Public list price: not published. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Develop Health to function | |
| Mapped pharmacy-benefit drug and specialty mix | PA automation fails on undefined formularies. |
| EHR workflow owners for prescribe-time checks | Side portals create dual entry. |
| Staff to review AI-drafted clinical answers | Unreviewed submissions create denial risk. |
| Clear escalation path for denials and appeals | Automation without appeals stalls starts. |
| Baseline approval rates and turnaround today | You cannot prove value without a baseline. |
| What will maximize your value | |
| Measure approval turnaround and medication start rates | Form completion alone is not the outcome. |
| Start with high-friction drug classes | Broad rollouts hide workflow bugs. |
| Train exception handling for unusual plans | Edge cases are the real workload. |
| Retire redundant fax and portal steps after go-live | Parallel processes erase ROI. |
| Review denial reasons weekly at first | Pattern misses become chronic churn. |
| Deal-breakers | |
| You need a payer UM policy engine. | |
| Your volume is almost entirely medical-benefit procedures. | |
| Clinicians will not review AI drafts. | |
| No EHR integration owner exists. | |
| Leadership expects zero denial exceptions. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Contract signed → kickoff | 2-6 weeks (security review, EHR scoping, payer or drug mix mapping) |
| 2 | Kickoff → first live workflow | 4-12 weeks for first specialty or site |
| 3 | First live workflow → steady value | 2-5 months before exception queues stabilize |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.